Long-Term Safety of Once-Daily 1.5-G Mesalamine Granules in Patients in Remission from Ulcerative Colitis

被引：0
|
作者：
Gordon, Glenn L.
Zakko, Salam
Murthy, Uma K.
Sedghi, Shahriar
Pruitt, Ron E.
Merchant, Kunal
Shaw, Audrey L.
Yuan, James
Bortey, Enoch
Forbes, William P.
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A521 / A521
页数：1
相关论文
共 50 条
  • [31] Long-term Compliance with Mesalamine Therapy in Patients with Quiescent Ulcerative Colitis: Results from a Long-term Phase IV Study of MMX® Mesalamine
    Kane, Sunanda
    Solomon, Dory
    Palmen, Mary
    Barrett, Karen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S458 - S459
  • [32] Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment
    Bresci, G.
    Parisi, G.
    Capria, A.
    COLORECTAL DISEASE, 2008, 10 (08) : 814 - 817
  • [33] Long Term Maintenance with Mesalamine Granules (1.5 g) in Patients Previously Treated with Corticosteroids is Associated with a Low Incidence of Ulcerative Colitis-Related Adverse Events
    Lichtenstein, Gary
    Gordon, Glenn
    Zakko, Salam
    Murthy, Uma
    Sedghi, Shahriar
    Pruitt, Ronald
    Yuan, James
    Merchant, Kunal
    Shaw, Audrey
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S460 - S460
  • [34] Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
    Dignass, Axel U.
    Bokemeyer, Bernd
    Adamek, Henning
    Mross, Michael
    Vinter-Jensen, Lars
    Boerner, Norbert
    Silvennoinen, Jouni
    Tan, Gie
    Pool, Marco Oudkerk
    Stijnen, Theo
    Dietel, Peter
    Klugmann, Tobias
    Vermeire, Severine
    Bhatt, Aomesh
    Veerman, Henri
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (07) : 762 - 769
  • [35] Once- or twice-daily MMX™ mesalamine for the maintenance of remission of mild or moderate ulcerative colitis
    Panaccione, Remo
    Kamm, Michael A.
    Karlstadt, Robyn
    Diebold, Ron
    Barrett, Karen
    Joseph, Raymond E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S463 - S463
  • [36] Randomized trial of once-daily or three-times-daily granulated Mesalamine equally effective for treatment of Ulcerative Colitis
    Kruis, W.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S27 - S27
  • [37] Long-Term Mesalamine Maintenance in Ulcerative Colitis: Which is More Important? Adherence or Daily Dose
    Khan, Nabeel
    Abbas, Ali M.
    Koleva, Yordanka N.
    Bazzano, Lydia A.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (06) : 1123 - 1129
  • [38] Long-term symptomatic remission of schizophrenia with once-daily extended release quetiapine fumarate
    Peuskens, Joseph
    Trivedi, Jitendra K.
    Brecher, Martin
    Svensson, Ola
    Miller, Frank
    Meulien, Didier
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 289S - 289S
  • [39] Pooled safety analysis of long-term, once-daily multimatrix mesalazine use
    Da Silva Sanchez, S.
    Wan, H.
    Streck, P.
    Willshire, D.
    Raskin, J. B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S349 - S349
  • [40] Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
    Sandborn, William J.
    Korzenik, Joshua
    Lashner, Bret
    Leighton, Jonathan A.
    Mahadevan, Uma
    Marion, James F.
    Safdi, Michael
    Sninsky, Charles A.
    Patel, Raman M.
    Friedenberg, Keith A.
    Dunnmon, Preston
    Ramsey, David
    Kane, Sunanda
    GASTROENTEROLOGY, 2010, 138 (04) : 1286 - U117
12345